KMID : 1225720180100010025
|
|
Allergy, Asthma & Immunology Research : AAIR 2018 Volume.10 No. 1 p.25 ~ p.33
|
|
Alteration in Claudin-4 Contributes to Airway Inflammation and Responsiveness in Asthma
|
|
Lee Pureun-Haneul
Kim Byeong-Gon Lee Sun-Hye Lee June-Hyuck Park Sung-Woo Kim Do-Jin Park Choon-Sik Leikauf George D. Jang An-Soo
|
|
Abstract
|
|
|
Purpose: Claudin-4 has been reported to function as a paracellular sodium barrier and is one of the 3 major claudins expressed in lung alveolar epithelial cells. However, the possible role of claudin-4 in bronchial asthma has not yet been fully studied. In this study, we aimed to elucidate the role of claudin-4 in the pathogenesis of bronchial asthma.
Methods: We determined claudin-4 levels in blood from asthmatic patients. Moreover, using mice sensitized and challenged with OVA, as well as sensitized and challenged with saline, we investigated whether claudin-4 is involved in the pathogenesis of bronchial asthma. Der p1 induced the inflammatory cytokines in NHBE cells.
Results: We found that claudin-4 in blood from asthmatic patients was increased compared with that from healthy control subjects. Plasma claudin-4 levels were significantly higher in exacerbated patients than in control patients with bronchial asthma. The plasma claudin-4 level was correlated with eosinophils, total IgE, FEV1% pred, and FEV1/FVC. Moreover, lung tissues from the OVA-OVA mice showed significant increases in transcripts and proteins of claudin-4 as well as in TJ breaks and the densities of claudin-4 staining. When claudin-4 was knocked down by transfecting its siRNA, inflammatory cytokine expressions, which were induced by Der p1 treatment, were significantly increased.
Conclusions: These findings thus raise the possibility that regulation of lung epithelial barrier proteins may constitute a therapeutic approach for asthma.
|
|
KEYWORD
|
|
Asthma, epithelial barrier, claudin-4
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|